These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 19956849

  • 1. The assessment of methylated BASP1 and SRD5A2 levels in the detection of early hepatocellular carcinoma.
    Tsunedomi R, Ogawa Y, Iizuka N, Sakamoto K, Tamesa T, Moribe T, Oka M.
    Int J Oncol; 2010 Jan; 36(1):205-12. PubMed ID: 19956849
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [Abstract] [Full Text] [Related]

  • 5. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L.
    Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889
    [Abstract] [Full Text] [Related]

  • 6. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 7. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.
    Qiu G, Fang J, He Y.
    Clin Biochem; 2006 Mar 15; 39(3):259-66. PubMed ID: 16516880
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S, Yeo W, Tang MW, Wong N, Lai PB, Johnson PJ.
    Clin Cancer Res; 2003 Aug 15; 9(9):3376-82. PubMed ID: 12960125
    [Abstract] [Full Text] [Related]

  • 11. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
    Gao W, Kondo Y, Shen L, Shimizu Y, Sano T, Yamao K, Natsume A, Goto Y, Ito M, Murakami H, Osada H, Zhang J, Issa JP, Sekido Y.
    Carcinogenesis; 2008 Oct 15; 29(10):1901-10. PubMed ID: 18632756
    [Abstract] [Full Text] [Related]

  • 12. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
    Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J.
    Carcinogenesis; 2010 May 15; 31(5):766-76. PubMed ID: 19843643
    [Abstract] [Full Text] [Related]

  • 13. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK, Kim H, Park HJ, Shim YH, Choi J, Park C, Park YN.
    Int J Mol Med; 2007 Jul 15; 20(1):65-73. PubMed ID: 17549390
    [Abstract] [Full Text] [Related]

  • 14. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ, Wang L, Wang JP, Li JQ, Zhang CQ, Zheng L, Yuan YF.
    Ai Zheng; 2006 Jun 15; 25(6):696-700. PubMed ID: 16764763
    [Abstract] [Full Text] [Related]

  • 15. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines].
    Zheng D, Liu BB, Liu YK, Kang XN, Sun L, Guo K, Sun RX, Chen J, Zhao Y.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec 15; 30(12):891-6. PubMed ID: 19173987
    [Abstract] [Full Text] [Related]

  • 16. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
    Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B, Dammann R.
    Oncogene; 2003 Mar 27; 22(12):1866-71. PubMed ID: 12660822
    [Abstract] [Full Text] [Related]

  • 17. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.
    Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447
    [Abstract] [Full Text] [Related]

  • 18. Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis.
    Yu J, Zhang HY, Ma ZZ, Lu W, Wang YF, Zhu JD.
    Cell Res; 2003 Oct 02; 13(5):319-33. PubMed ID: 14672555
    [Abstract] [Full Text] [Related]

  • 19. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z, Zhang M, Bi J, Xu F, Hu S, Wen J.
    Am J Clin Pathol; 2006 May 02; 125(5):740-6. PubMed ID: 16707376
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.